![Diego Miralles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Diego Miralles
Präsident bei
ARTIVA BIOTHERAPEUTICS, INC.
Vermögen: 614 575 $ am 31.05.2026
Profil
Diego Miralles is currently Director at S.V.D.P.
Management, Inc. since 2025, Director at ArrePath, Inc., Director at Contineum Therapeutics, Inc. since 2025, Director at Rady Children's Institute for Genomic Medicine since 2008, President & Head-Research & Development at Artiva Biotherapeutics, Inc. starting 2026, and Venture Partner at CHP Management, Inc. Former roles include President, Chief Executive Officer & Director at Laronde, Inc. from 2020 to 2022, Chief Executive Officer & Director at Vividion Therapeutics, Inc. from 2017 to 2020, Director at NeuBase Therapeutics, Inc. from 2019 to 2021, Medical Director at Triangle Pharmaceuticals, Inc. from 1998 to 2000, Senior Director at Trimeris, Inc. from 2000 to 2005, Advisor at Flagship Pioneering, Inc. from 2022 to 2023, President at Adaptive Therapeutics, Inc. from 2016 to 2017, Assistant Professor at Duke University Medical Center, Member-Management Board at Tibotec Virco Virology BV, and Director at CONNECT.
Education includes a doctorate from Universidad de Buenos Aires conferred in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 77 500 ( 0,16 % ) | 614 575 $ | 31.05.2026 | |
| 17.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Diego Miralles
| Unternehmen | Position | Beginn |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 14.03.2025 |
| ARTIVA BIOTHERAPEUTICS, INC. | Präsident | 18.05.2026 |
S.V.D.P. Management, Inc.
 S.V.D.P. Management, Inc. Miscellaneous Commercial ServicesCommercial Services Provides one-stop shopping services | Direktor/Vorstandsmitglied | 01.03.2025 |
Rady Children's Institute for Genomic Medicine | Direktor/Vorstandsmitglied | 01.01.2008 |
CHP Management, Inc.
 CHP Management, Inc. Investment ManagersFinance Cardinal Partners invests in companies located in the United States. The firm focuses on life sciences, virtual care, machine learning/NLP/blockchain, disruptive healthcare technology and consumer sectors. It provides financing for early, growth and recapitalization transactions with an investment size of USD 6 - 12 million. | Private Equity Investor | - |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ArrePath, Inc.
 ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Diego Miralles
| Unternehmen | Position | Ende |
|---|---|---|
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Vorstandsvorsitzender | 01.09.2022 |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Vorstandsvorsitzender | 30.09.2022 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Diego Miralles
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antiviral drug candidates | Commercial Services |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance Cardinal Partners invests in companies located in the United States. The firm focuses on life sciences, virtual care, machine learning/NLP/blockchain, disruptive healthcare technology and consumer sectors. It provides financing for early, growth and recapitalization transactions with an investment size of USD 6 - 12 million. | Finance |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Therapeutics, Inc.
 Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
S.V.D.P. Management, Inc.
S.V.D.P. Management, Inc. Miscellaneous Commercial ServicesCommercial Services Provides one-stop shopping services | Commercial Services |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
Tibotec Virco Virology BV | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Neubase Therapeutics, Inc. /Old/
 Neubase Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide-nucleic acid antisense oligonucleotide platform | Health Technology |
Rady Children's Institute for Genomic Medicine | |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
ArrePath, Inc.
ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Health Technology |
